Volker Muschalek, a member of MWG Biotech's management board for operations, human resources, IT, and India, resigned from his position this week, the company said.
Muschalek had served as the company's chief operating officer and had been co-managing the company with Wolfgang Pieken following the departure of board chairman Thomas Becker last year.
Russell Bradley has become vice president of business development and strategic planning of Luminex, the Austin, Texas-based company said last week. In addition, Gregory Gosch has become vice president of marketing and sales, and Randel Marfin vice president of the Luminex Bioscience Group, a new position.
Most recently, Bradley was director of Beckman Coulter's Cares initiative. He holds a BS in immunology and biochemistry from Monash University in Australia.
Roger Wiegand has become director of the infectious disease initiative at the Broad Institute, BioArray News has learned. Prior to joining the Broad, he was chief scientific officer of Cantata Laboratories in Cambridge, Mass.